- Home
- CRDF vs EXFY Comparison
CRDF vs EXFY Comparison
Compare CRDF & EXFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDF
- EXFY
- Stock Information
- Founded
- CRDF 1999
- EXFY 2008
- Country
- CRDF United States
- EXFY United States
- Employees
- CRDF N/A
- EXFY N/A
- Industry
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- EXFY Computer Software: Prepackaged Software
- Sector
- CRDF Health Care
- EXFY Technology
- Exchange
- CRDF Nasdaq
- EXFY Nasdaq
- Market Cap
- CRDF 288.7M
- EXFY 341.6M
- IPO Year
- CRDF N/A
- EXFY 2021
- Fundamental
- Price
- CRDF $4.75
- EXFY $3.26
- Analyst Decision
- CRDF Strong Buy
- EXFY Buy
- Analyst Count
- CRDF 3
- EXFY 4
- Target Price
- CRDF $10.33
- EXFY $3.50
- AVG Volume (30 Days)
- CRDF 971.7K
- EXFY 342.6K
- Earning Date
- CRDF 02-27-2025
- EXFY 02-27-2025
- Dividend Yield
- CRDF N/A
- EXFY N/A
- EPS Growth
- CRDF N/A
- EXFY N/A
- EPS
- CRDF N/A
- EXFY N/A
- Revenue
- CRDF $688,000.00
- EXFY $137,440,000.00
- Revenue This Year
- CRDF $25.03
- EXFY N/A
- Revenue Next Year
- CRDF N/A
- EXFY $6.06
- P/E Ratio
- CRDF N/A
- EXFY N/A
- Revenue Growth
- CRDF 49.57
- EXFY N/A
- 52 Week Low
- CRDF $1.65
- EXFY $1.24
- 52 Week High
- CRDF $6.42
- EXFY $4.13
- Technical
- Relative Strength Index (RSI)
- CRDF 62.77
- EXFY 37.15
- Support Level
- CRDF $4.12
- EXFY $3.31
- Resistance Level
- CRDF $4.38
- EXFY $4.00
- Average True Range (ATR)
- CRDF 0.38
- EXFY 0.23
- MACD
- CRDF 0.04
- EXFY -0.06
- Stochastic Oscillator
- CRDF 80.17
- EXFY 1.33
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical program in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC").
About EXFY Expensify Inc.
Expensify Inc is a cloud-based expense management software platform that helps various businesses simplify the way to manage money. It is used to scan and reimburse receipts from flights, hotels, coffee shops, office supplies and ride shares. People use Expensify's free features, which include corporate cards, expense tracking, next-day reimbursement, invoicing, bill pay, and travel booking in one app.